PACTR202108476131561尚未招募未知
A Multi-Center Randomized Controlled Trial of Behavioral, Educational and Mixed Interventions for Improving Adherence to Glaucoma Medications
BENJAMIN ABAIDOO0 个研究点目标入组 160 人开始时间: 2021年7月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •1.Previously diagnosed adult glaucoma patients aged 18 to 70 years.
- •2.Diagnosed of glaucoma for one or more years.
- •3.Prescribed and advised to use topical anti-glaucoma medications.
- •4.Patients who have used topical anti-glaucoma medications for one or more years.
- •5.Patients who are non-adherent (the extent to which medication intake behaviour by patients does not corresponds with the recommendations of the health care provider) to glaucoma medication.
排除标准
- •1.Glaucoma diagnosed patients who underwent glaucoma surgery as this was thought to be a motivator for medication adherence.
- •2.Patients with coexisting psychiatric disorders.
研究者
相似试验
已完成
不适用
A multi-centre, randomised, controlled trial of bronchoalveolar lavage (BAL) directed therapy in young children with cystic fibrosis (CF).Human Genetics and Inherited Disorders - Cystic fibrosisCystic FibrosisACTRN12605000665639HMRC165
已完成
不适用
Randomized controlled trial for evaluation of behavior change by peer support type habituation app for people who are actively supported by specific health guidance(PEER-App Study)JPRN-UMIN000046892Tokai University88
进行中（未招募）
1 期
A clinical study investigating the efficacy, tolerability and safety of brexpiprazole for the acute treatment of manic episodes, with or without mixed features, in subjects with a diagnosis of bipolar I disorderEUCTR2017-002190-20-HROtsuka Pharmaceutical Development & Commercialization, Inc.333
进行中（未招募）
1 期
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole versus Placebo for the Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With Bipolar I DisorderEUCTR2017-002222-20-PLOtsuka Pharmaceutical Development & Commercialization, Inc.322
进行中（未招募）
1 期
A clinical study investigating the efficacy, tolerability and safety of brexpiprazole for the acute treatment of manic episodes, with or without mixed features, in subjects with a diagnosis of bipolar I disorderTreatment of Manic Episodes Associated with Bipolar I DisorderMedDRA version: 20.0Level: LLTClassification code 10068455Term: Bipolar I disorder, hypomanicSystem Organ Class: 100000004873EUCTR2017-002222-20-BGOtsuka Pharmaceutical Development & Commercialization, Inc.322